Too much AKT turns PAX3-FKHR dead: A prospect of novel therapeutic strategy for alveolar rhabdomyosarcoma

  • Jothi M
  • Mal A
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

This study suggests that AKT could promote tumor differentiation in certain setting. PAX3-FKHR abolition in ARMS cells led to terminal differentiation, therefore, it is worth considering the potential role of AKT activation-dependent inactivation of PAX3-FKHR in this effort. Taken together, we venture that acute AKT activation should be evaluated for therapeutic benefit in ARMS and also in certain types of tumor.

Cite

CITATION STYLE

APA

Jothi, M., & Mal, A. K. (2012). Too much AKT turns PAX3-FKHR dead: A prospect of novel therapeutic strategy for alveolar rhabdomyosarcoma. Oncotarget, 3(10). https://doi.org/10.18632/oncotarget.713

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free